A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-κB or ODC transactivation

Oncogene

Volumn 20, Issue 6, 2001, Pages 669-676

  Yang, Hsin Sheng ^a   Jansen, Aaron P ^b   Nair, Rajalakshmi ^a   Shibahara, Keiichi ^c   Verma, Ajit K ^b   Cmarik, Joan L ^a   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

AP 1; NF B; Pdcd4; Transformation

Indexed keywords

COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; ORNITHINE DECARBOXYLASE; PROTEIN PDCD 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL TRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIDERMIS CELL; MALIGNANT TRANSFORMATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR GENE; TRANSACTIVATION; TUMOR PROMOTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; MICE; NF-KAPPA B; ORNITHINE DECARBOXYLASE; PROTEINS; RNA-BINDING PROTEINS; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 0035825611     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204137     Document Type: Article

References (41)